Correlation Between Amneal Pharmaceuticals, and Neurocrine Biosciences
Can any of the company-specific risk be diversified away by investing in both Amneal Pharmaceuticals, and Neurocrine Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Amneal Pharmaceuticals, and Neurocrine Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Amneal Pharmaceuticals, Class and Neurocrine Biosciences, you can compare the effects of market volatilities on Amneal Pharmaceuticals, and Neurocrine Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Amneal Pharmaceuticals, with a short position of Neurocrine Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Amneal Pharmaceuticals, and Neurocrine Biosciences.
Diversification Opportunities for Amneal Pharmaceuticals, and Neurocrine Biosciences
0.07 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Amneal and Neurocrine is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding Amneal Pharmaceuticals, Class and Neurocrine Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurocrine Biosciences and Amneal Pharmaceuticals, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Amneal Pharmaceuticals, Class are associated (or correlated) with Neurocrine Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurocrine Biosciences has no effect on the direction of Amneal Pharmaceuticals, i.e., Amneal Pharmaceuticals, and Neurocrine Biosciences go up and down completely randomly.
Pair Corralation between Amneal Pharmaceuticals, and Neurocrine Biosciences
Given the investment horizon of 90 days Amneal Pharmaceuticals, Class is expected to generate 1.93 times more return on investment than Neurocrine Biosciences. However, Amneal Pharmaceuticals, is 1.93 times more volatile than Neurocrine Biosciences. It trades about 0.09 of its potential returns per unit of risk. Neurocrine Biosciences is currently generating about 0.01 per unit of risk. If you would invest 221.00 in Amneal Pharmaceuticals, Class on August 28, 2024 and sell it today you would earn a total of 617.00 from holding Amneal Pharmaceuticals, Class or generate 279.19% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Amneal Pharmaceuticals, Class vs. Neurocrine Biosciences
Performance |
| Timeline |
| Amneal Pharmaceuticals, |
| Neurocrine Biosciences |
Amneal Pharmaceuticals, and Neurocrine Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Amneal Pharmaceuticals, and Neurocrine Biosciences
The main advantage of trading using opposite Amneal Pharmaceuticals, and Neurocrine Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Amneal Pharmaceuticals, position performs unexpectedly, Neurocrine Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurocrine Biosciences will offset losses from the drop in Neurocrine Biosciences' long position.| Amneal Pharmaceuticals, vs. Alkermes Plc | Amneal Pharmaceuticals, vs. Neurocrine Biosciences | Amneal Pharmaceuticals, vs. Intracellular Th | Amneal Pharmaceuticals, vs. Dynavax Technologies |
| Neurocrine Biosciences vs. Amphastar P | Neurocrine Biosciences vs. Collegium Pharmaceutical | Neurocrine Biosciences vs. Ironwood Pharmaceuticals | Neurocrine Biosciences vs. ANI Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |